Citations to this article

Complement system on the attack in autoimmunity
John P. Atkinson
John P. Atkinson
Published December 1, 2003
Citation Information: J Clin Invest. 2003;112(11):1639-1641. https://doi.org/10.1172/JCI20309.
View: Text | PDF
Commentary

Complement system on the attack in autoimmunity

Abstract

The antiphospholipid syndrome is characterized clinically by fetal loss and thrombosis and serologically by the presence of autoantibodies to lipid-binding proteins. In a model of this procoagulant condition in which these antibodies are injected into pregnant mice, fetal loss was prevented by blocking of complement activation. Specifically, interaction of complement component 5a (C5a) with its receptor is necessary for thrombosis of placental vasculature (see the related article beginning on page 1644). Inhibition of complement activation may have a therapeutic role in this disease.

Authors

John P. Atkinson

×

Total citations by year

Year: 2022 2019 2016 2009 2008 2004 Total
Citations: 1 1 1 1 2 1 7
Citation information

Citations to this article in year 2019 (1)

Title and authors Publication Year
Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
SL Savelli, RA Roubey, KJ Kitzmiller, D Zhou, HN Nagaraja, E Mulvihill, F Barbar-Smiley, SP Ardoin, YL Wu, CY Yu 		Frontiers in immunology 2019

Advertisement